Zn(II)-Driven Impact of Monomeric Transthyretin on Amyloid-beta Amyloidogenesis

20 February 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


Extracellular accumulation of amyloid-beta (Abeta) peptides in the brain plays a significant role in the development of Alzheimer's disease (AD). While the co-localization and interaction of proteins and metal ions with Abeta in extracellular milieu are established, their precise pathogenic associations remain unclear. Here we report the impact of Zn(II) on the anti-amyloidogenic properties of monomeric transthyretin (M-TTR), which coexists spatially with Abeta and Zn(II) in extracellular fluids. Our findings demonstrate the Zn(II)-promoted ternary complex formation involving M-TTR, Abeta40, and Zn(II) as well as M-TTR's proteolytic activity towards Abeta40. These interactions alter the inhibitory effect of M-TTR on Abeta40 amyloidogenesis, particularly affecting the primary nucleation process, and mitigate the cytotoxicity induced by Abeta40. This study unveils the variable activities of M-TTR towards Abeta40, driven by Zn(II), providing insights into how metal ions influence the entanglement of M-TTR in the Abeta-related pathology linked to AD.


Monomeric transthyretin
Amyloid-beta amyloidogenesis
Anti-amyloidogenic activity
Ternary complexation
Alzheimer’s disease

Supplementary materials

Supplementary Information
Experimental, Figures S1-S19, and Table S1


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.